Chemomab Therapeutics Ltd logo

Chemomab Therapeutics Ltd (CMMB)

$0.86

Chemomab Therapeutics Ltd (CMMB) Share Price Forecast
Currently 8 wall-street analysts regularly analyze the financials of Chemomab Therapeutics Ltd on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Chemomab Therapeutics Ltd (CMMB) have a share price target of $5.67. This median of share price forecast represents a 559.3% upside from the latest price of $0.86 as on 22.05.24.

Chemomab Therapeutics Ltd (CMMB) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Chemomab Therapeutics Ltd (CMMB) share price will touch around $5.67 in next 12-months.
Chemomab Therapeutics Ltd (CMMB) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Chemomab Therapeutics Ltd's share price and its median forecast price. As on 22.05.24, the difference is -87.21%

Chemomab Therapeutics Ltd (CMMB): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Chemomab Therapeutics Ltd (CMMB) Share Price : Analyst Recommendation
Based on 8 analysts tracking and researching Chemomab Therapeutics Ltd (CMMB) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
0
0
4
Outperform
0
0
2
Hold
3
3
2
Underperform
2
2
0
Sell
1
1
0
Chemomab Therapeutics Ltd (CMMB) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Chemomab Therapeutics Ltd (CMMB) is $5.67, offered by 8 analysts offering 12-month price forecasts.

Chemomab Therapeutics Ltd (CMMB) has a maximum of 5.59 upside potential, based on 8 analysts offering 12-month price forecasts.

Based on 8 analysts tracking and researching Chemomab Therapeutics Ltd (CMMB), 75% have a buy recommendation. Remaining 25% have either sell or hold recommendations.

The latest share price of Chemomab Therapeutics Ltd (CMMB) is $0.86 as of 22/05/2024.

6 of total 8 analysts offering stock ratings for Chemomab Therapeutics Ltd CMMB have recommended buy rating.